Startseite › Akute myeloische Leukämie › Georgia › Atlanta
Klinische Studien zu Akute myeloische Leukämie in Atlanta, GA
31 Studien zu Akute myeloische Leukämie suchen Teilnehmer an Standorten in und um Atlanta (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Teilnehmer gesuchtPhase 1
- Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
Ivosidenib as Post-HSCT Maintenance for AML
Teilnehmer gesuchtPhase 2
- Emory University Hospital, Atlanta
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Teilnehmer gesuchtPhase 1
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Teilnehmer gesuchtPhase 2/3
- Winship Cancer Institute of Emory University /ID# 279006, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Atlanta VA Medical Center, Decatur · 6 mi entfernt
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Teilnehmer gesuchtBeobachtungsstudie
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Teilnehmer gesuchtPhase 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Teilnehmer gesuchtPhase 1
- Emory University, Atlanta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Teilnehmer gesuchtPhase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Teilnehmer gesuchtPhase 1/2
- Emory Winship Cancer Institute, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Teilnehmer gesuchtPhase 2
- Winship Cancer Institute - Emory University, Atlanta
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Teilnehmer gesuchtPhase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Teilnehmer gesuchtPhase 3
- US-Atlanta GA-EMORY, Atlanta
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Teilnehmer gesuchtPhase 3
- US-Atlanta GA-EMORY, Atlanta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Teilnehmer gesuchtPhase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Teilnehmer gesuchtPhase 3
- Children's Healthcare of Atlanta, Atlanta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Teilnehmer gesuchtPhase 1
- Emory Healthcare - The Emory Clinic, Atlanta
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Teilnehmer gesuchtPhase 1
- Children's Healthcare of Atlanta, Atlanta
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Teilnehmer gesuchtPhase 1Gesunde Freiwillige willkommen
- Northside Hospital, Atlanta
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Teilnehmer gesuchtPhase 3
- Emory University - Winship Cancer Institute (WCI), Atlanta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Teilnehmer gesuchtBeobachtungsstudie
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Teilnehmer gesuchtPhase 1/2
- Emory Winship Cancer Institute, Atlanta
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Teilnehmer gesuchtPhase 1
- Winship Cancer Institute / Emory University, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Teilnehmer gesuchtPhase 2/3
- University of Emory - Winship Cancer Institute, Atlanta
Pilot Imaging Study of Leukemia
Teilnehmer gesuchtPhase 1
- Emory University, Atlanta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Teilnehmer gesuchtPhase 1
- Emory Healthcare - The Emory Clinic, Atlanta
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Teilnehmer gesuchtPhase 2Gesunde Freiwillige willkommen
- Northside Hospital, Atlanta
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Teilnehmer gesuchtPhase 1
- Emory University Hospital, Atlanta
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Teilnehmer gesuchtPhase 1
- Emory University - WINSHIP Cancer Center, Atlanta
- Emory University, Children's Healthcare of Atlanta, Atlanta
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Teilnehmer gesuchtPhase 1
- Blood and Marrow Transplant Group of Georgia, Atlanta
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Emory University, Atlanta
Akute myeloische Leukämie-Studien in anderen Städten
- Houston, TX85 Studien
- New York City, NY51 Studien
- Boston, MA44 Studien
- Seattle, WA41 Studien
- Baldwin Park, CA40 Studien
- Columbus, OH35 Studien
- Philadelphia, PA34 Studien
- Durham, NC33 Studien
- Tampa, FL29 Studien
- Chicago, IL26 Studien
- Portland, OR25 Studien
- Washington, DC24 Studien
Weitere Studien in Atlanta
- Krebs (alle Arten)49 Studien
- Nichtkleinzelliges Lungenkarzinom47 Studien
- Multiples Myelom42 Studien
- Brustkrebs41 Studien
- Prostatakrebs33 Studien
- Eierstockkrebs29 Studien
- Kolorektales Karzinom29 Studien
- Lungenkrebs29 Studien
- Metastasierender Krebs28 Studien
- Major Depression25 Studien
- Herzinsuffizienz25 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich24 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.